Back to Search
Start Over
105 - Very Low-Dose Decitabine is Effective in Treating Intermediate or High Risk Myelodysplastic Syndrome.
- Source :
-
Leukemia Research . Apr2017 Supplement 1, Vol. 55, pS65-S66. 1p. - Publication Year :
- 2017
- Subjects :
- *DECITABINE
*MYELODYSPLASTIC syndromes treatment
*DRUG efficacy
*THERAPEUTICS
Subjects
Details
- Language :
- English
- ISSN :
- 01452126
- Volume :
- 55
- Database :
- Academic Search Index
- Journal :
- Leukemia Research
- Publication Type :
- Academic Journal
- Accession number :
- 123868608
- Full Text :
- https://doi.org/10.1016/S0145-2126(17)30218-7